Dynamic Change of Focal Fatty Sparing in Non-Alcoholic Fatty Liver Disease after Treatment with Sitagliptin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Dynamic Change of Focal Fatty Sparing in Non-Alcoholic Fatty Liver Disease after Treatment with Sitagliptin ; volume:02 ; number:03 ; year:2016 ; pages:E98-E99
Ultrasound international open ; 02, Heft 03 (2016), E98-E99
- Contributor
-
Hoffmanová, I.
Škrha, P.
Šedo, A.
Anděl, M.
- DOI
-
10.1055/s-0036-1582302
- URN
-
urn:nbn:de:101:1-2018102611113482396978
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoffmanová, I.
- Škrha, P.
- Šedo, A.
- Anděl, M.
Other Objects (12)
Non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
Dietary patterns and risk of non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
Dietary patterns and risk of non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
Elevated endotoxin levels in non-alcoholic fatty liver disease
Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease
Dietary patterns and risk of non-alcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease